A Cu2+ Probe over Nizatidine and Ranitidine, or In Silico Vs. Experimentally Obtained Complexation of Drugs


Article Preview

In silico model of title drugs mode of interaction with Cu2+ ion was proposed. A hundred conformations of each drug are used in this study. Examination of drugs interactions with Cu2+ ion were conducted using GRID package. The Cu2+ probe was used. The two favorable regions of interactions were detected: a) the nitro group and terminal imino nitrogen in a γ position from it, as proposed from the experimental data, b) the region of heterocyclic ring (tiazoline and furan from Nizatidine and Ranitidine, respectively) as the most favorable one. Therefore, the present study identifies the second region of the molecule that is able to strongly interact with the Cu2+ ion. The position and energies of obtained molecular interaction fields (MIF) are discussed. The results support the fact that the properties, which express recognition forces of the molecules, are strongly dependent on 3D geometry.



Edited by:

Dragan P. Uskoković, Slobodan K. Milonjić and Dejan I. Raković




B.J. Drakulić and S.P. Sovilj, "A Cu2+ Probe over Nizatidine and Ranitidine, or In Silico Vs. Experimentally Obtained Complexation of Drugs", Materials Science Forum, Vol. 555, pp. 435-439, 2007

Online since:

September 2007




[1] S.P. Sovilj, A. Džambaski and T. Jovanović: Asian Journal of Chemistry Vol. 15(1) (2003), p.19.

[2] M. Mathur, S. Shrivastava and N.M. Shrivastava: Asian Journal of Chemistry Vol. 12(2) (2000), p.371.

[3] Freely assessable at: http: /bioinformatics. charite. de/superdrug.

[4] Catalyst 4, 7, distributed by Accelrys, San Diego CA, USA.

[5] A. Pedretti, L. Villa and G. Vistoli: VEGA - An open platform to develop chemo-bioinformatics applications, using plug-in architecture and script programming: Jour. Comp. Aid. Mol. Des. Vol. 18(3) (2004), p.167; http: /www. ddl. unimi. it.

DOI: https://doi.org/10.1023/b:jcam.0000035186.90683.f2

[6] a) GRID version 22b, distributed by Molecular Discovery Ltd., UK; For the GRID functionality, commands and options see the GRID manual @ http: /www. moldiscovery. com/docs/grid/; b) Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules: J. Med. Chem. Vol. 28(7) (1985).

DOI: https://doi.org/10.1002/chin.198544341

[7] R.B. Silverman: The Organic Chemistry of the Drug Design and Drug Action (Elsevier 2004) pp.159-165; and cited references.

[8] G. Vistoli, A. Pedretti, L. Villa and B. Testa: J. Med. Chem. Vol. 48(15) (2005), p.4947.